All Stories

  1. Development and Validation of the Melanoma Cancer Awareness Measure
  2. Making Teledermatology Services Work: A Realist Review of Success Factors
  3. Charting a new melanoma risk factor: Satellite Naevus Prevalence in High-Risk and Population-Based Cohorts
  4. Nevus clustering on the back associated with in situ melanoma in a Queensland melanoma high-risk cohort
  5. Diagnosis of a case of scabies infestation with line-field confocal optical coherence tomography
  6. Psychological Wellbeing After a Diagnosis of Melanoma In Situ: A Qualitative Interview Study
  7. 3D-total body photography identifies cutaneous phenotypes associated with late-onset invasive melanoma risk
  8. The Impact of Multidisciplinary Research on Progress in Skin Cancer Prevention
  9. The Venous Garland of Sahli
  10. An Overview of Data Analysis Approaches and Biases in Unveiling the Impact of COVID-19 on Melanoma Diagnosis
  11. A longitudinal dataset of tile and corresponding dermoscopic images with metadata for identifying skin cancers
  12. Three-Dimensional Total Body Photography Enables Automated Obesity-Related Comorbidity Screening in Dermatology
  13. Germline CDKN2A Variant Cascade Testing Across Four Generations Reveals Familial Melanoma–Breast Cancer Genotype–Phenotype Correlation
  14. Privacy in Imaging for Dermatology Research
  15. What Are Patients’ Perceptions and Attitudes Regarding the Use of Artificial Intelligence in Skin Cancer Screening and Diagnosis? Narrative Review
  16. Unpredictable interdependence of invasive and in situ melanoma
  17. Mitochondrial Deletion4977 Abundance in Melanoma-Adjacent Skin
  18. Attitudes Towards the Use of Artificial Intelligence in Dermatology: A Survey of Australian Dermatologists
  19. The deep imaging phenotype for melanoma risk stratification
  20. Estimation of Body Mass Index from 3-Dimensional Total Body Photography
  21. Exploring the Views of Dermatologists, General Practitioners, and Melanographers on the Use of AI Tools in the Context of Good Decision-Making When Detecting Melanoma: Qualitative Interview Study
  22. Combining Automated Lesion Risk and Change Assessment Improves Melanoma Detection: A Retrospective Accuracy Study
  23. A tissue multiplexing approach to maximise spatial transcriptomics output from precious pathology specimens
  24. Clinical Features and Risks of Congenital Melanocytic Naevi: A Retrospective Analysis of Patients at the Queensland Children's Hospital
  25. Skin 2.0: How Cutaneous Digital Twins Could Reshape Dermatology
  26. Beta‐Blockers and Cutaneous Melanoma Outcomes: A Systematic Review and Random‐Effects Meta‐Analysis
  27. Prompt-Driven Latent Domain Generalization for Medical Image Classification
  28. Incidence and patterns of newly developed pigmented lesions in adults at high risk for melanoma
  29. Location matters! Optimizing venue selection and attendance format to lower the carbon footprint of air travel to the Australasian College of Dermatologists ASM
  30. Automated Detection of Pigmented Iris Freckles Using a Deep Neural Network for Cutaneous Melanoma Risk
  31. Uncovering the molecular mechanisms of amelanotic/hypopigmented primary cutaneous melanoma
  32. Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study
  33. Diversifying dermatology: Improving skin of colour representation
  34. Exploring the Views of Dermatologists, General Practitioners, and Melanographers on the Use of AI Tools in the Context of Good Decision-Making When Detecting Melanoma: Qualitative Interview Study (Preprint)
  35. A Narrative Review: Opportunities and Challenges in Artificial Intelligence Skin Image Analyses Using Total Body Photography
  36. Examining labelling guidelines for AI‐based software as a medical device: A review and analysis of dermatology mobile applications in Australia
  37. MicroRNA Expression Profiling of Cutaneous Squamous Cell Carcinomas and Precursor Lesions
  38. The Skin Molecular Ecosystem Holds the Key to Nevogenesis and Melanomagenesis
  39. Minimum labelling requirements for dermatology artificial intelligence‐based Software as Medical Device (SaMD): A consensus statement
  40. Re: Incidence of in situ vs invasive melanoma: testing the “obligate precursor” hypothesis
  41. Assessing the genetic risk of nodular melanoma using a candidate gene approach
  42. Distinct HOX Gene Family DNA Methylation Profiles in Histologically Normal Skin Dependent on Dermoscopic Pattern of Adjacent Nevi
  43. Improving Artificial Intelligence−Based Diagnosis on Pediatric Skin Lesions
  44. GOLM1: expanding our understanding of melanoma susceptibility
  45. Spatial Randomness in the Distribution of Acquired Melanocytic Nevi of the Back in a Population-Based Sample
  46. Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy
  47. Patterns and cost of care according to keratinocyte cancer risk stratification in a volunteer population screening clinic: Real‐world data from the TRoPICS study
  48. Consumer views of melanoma early detection using 3D total‐body photography: cross‐sectional survey
  49. Skin cancer excisions and histopathology outcomes when following a contemporary population‐based cohort longitudinally with 3D total‐body photography
  50. Artificial Intelligence for the Classification of Pigmented Skin Lesions in Populations with Skin of Color: A Systematic Review
  51. Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
  52. Protocol to evaluate a pilot program to upskill clinicians in providing genetic testing for familial melanoma
  53. The dynamic nature of naevi in adulthood: prospective population-based study using three-dimensional total-body photography
  54. Consumer perceptions on privacy and confidentiality in dermatology for 3D total‐body imaging
  55. Basal cell carcinomas in organ transplant recipients versus the general population: clinicopathologic study
  56. Can people take high‐quality images using mobile dermatoscopes at home on easy‐to‐see and difficult‐to‐see body areas?
  57. Body Site Distribution of Acquired Melanocytic Naevi and Associated Characteristics in the General Population of Caucasian Adults: A Scoping Review
  58. Assessing the Generalizability of Deep Learning Models Trained on Standardized and Nonstandardized Images and Their Performance Against Teledermatologists: Retrospective Comparative Study
  59. Amelanotic/hypopigmented melanoma in a sibship with oculocutaneous albinism
  60. Genome-Scale DNA Methylation Analysis Identifies Repeat Element Alterations that Modulate the Genomic Stability of Melanocytic Nevi
  61. Perspectives and experiences of patient-led melanoma surveillance using digital technologies from clinicians involved in the MEL-SELF pilot randomised controlled trial: Qualitative Interview Study (Preprint)
  62. Digital Technology in Skin Cancer Prevention and Early Detection
  63. Changes in the skin microbiome associated with squamous cell carcinoma in transplant recipients
  64. Digital Technology in Skin Cancer Prevention and Early Detection (Preprint)
  65. Training and Retaining Physician‒Scientists in Dermatology: Australia
  66. Polygenic Risk Scores Stratify Keratinocyte Cancer Risk among Solid Organ Transplant Recipients with Chronic Immunosuppression in a High Ultraviolet Radiation Environment
  67. Factors influencing participants’ engagement with an interactive text-message intervention to improve sun protection behaviors: “SunText” randomized controlled trial
  68. Subtype-Specific Analyses Reveal Infiltrative Basal Cell Carcinomas Are Highly Interactive with their Environment
  69. A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients
  70. An Australian tertiary hospital analysis of outpatient dermatology clinical and demographic characteristics
  71. An Integrated Microfluidic‐SERS Platform Enables Sensitive Phenotyping of Serum Extracellular Vesicles in Early Stage Melanomas
  72. Reproducible Naevus Counts Using 3D Total Body Photography and Convolutional Neural Networks
  73. High variability in anatomic patterns of cutaneous photodamage: a population‐based study
  74. Estimating the potential impact of interventions to reduce over‐calling and under‐calling of melanoma
  75. The Distinctive Genomic Landscape of Giant Congenital Melanocytic Nevi
  76. Mutation Signatures in Melanocytic Nevi Reveal Characteristics of Defective DNA Repair
  77. Review of smartphone mobile applications for skin cancer detection: what are the changes in availability, functionality, and costs to users over time?
  78. Virtual melanoma checks during a pandemic
  79. A CLOSE‐UP guide to capturing clinical images
  80. Real‐time teledermatology clinics in a tertiary public hospital: A clinical audit
  81. Practice guidelines for teledermatology in Australia
  82. A review of literature supporting the development of practice guidelines for teledermatology in Australia
  83. Long‐term deaths from melanoma according to tumor thickness at diagnosis
  84. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls
  85. Self‐reported naevus density may lead to misclassification of melanoma risk
  86. 3D Total Body Photography for early melanoma detection
  87. Smartphones, artificial intelligence and digital histopathology take on basal cell carcinoma diagnosis
  88. High naevus count and MC 1R red hair alleles contribute synergistically to increased melanoma risk
  89. Fighting Melanoma with Smartphones: A Snapshot of Where We are a Decade after App Stores Opened Their Doors
  90. Why a randomized melanoma screening trial may be a good idea
  91. ‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi
  92. Unexpected positron emission tomography/computed tomography uptake in benign dermal naevus
  93. Iris pigmented lesions as a marker of cutaneous melanoma risk: an Australian case-control study
  94. Point mutation in p14ARF -specific exon 1β of CDKN2A causing familial melanoma and astrocytoma
  95. Automated diagnosis: shedding the light on skin cancer
  96. The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation
  97. Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1
  98. Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014
  99. Do hand-addressed envelopes improve community response rates for a longitudinal study?
  100. Clinical comparison of actinic changes preceding squamous cell carcinoma vs. intraepidermal carcinoma in renal transplant recipients
  101. Patients’ and doctors’ preferences for disclosing dermatology results
  102. Dermoscopy of a pigmented apocrine porocarcinoma arising from a pigmented hidroacanthoma simplex
  103. Diphenylcyclopropenone for the treatment of cutaneous in-transit melanoma metastases - results of a prospective, non-randomized, single-centre study
  104. The natural history of common melanocytic naevi: a systematic review of longitudinal studies in the general population
  105. GSTP1 does not modify MC1R effects on melanoma risk
  106. Consumer teledermoscopy for melanoma diagnosis
  107. Concurrent Reflectance Confocal Microscopy and Laser Doppler Flowmetry to Improve Skin Cancer Imaging: A Monte Carlo Model and Experimental Validation
  108. Validity and Reliability of Dermoscopic Criteria Used to Differentiate Nevi From Melanoma
  109. Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia
  110. Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformation
  111. A mutation in theCdongene potentiates congenital nevus development mediated by NRASQ61K
  112. Histopathology and reflectance confocal microscopy features of photodamaged skin and actinic keratosis
  113. Economics of teledermatology
  114. Standardization of terminology in dermoscopy/dermatoscopy: Results of the third consensus conference of the International Society of Dermoscopy
  115. Automated Segmentation of Skin Strata in Reflectance Confocal Microscopy Depth Stacks
  116. Teledermatology and clinical photography: safeguarding patient privacy and mitigating medico-legal risk
  117. Ten-Year Survival after Multiple Invasive Melanomas Is Worse than after a Single Melanoma: a Population-Based Study
  118. Skin microbiopsy for HPV DNA detection in cutaneous warts
  119. Heritability of naevus patterns in an adult twin cohort from the Brisbane Twin Registry: a cross-sectional study
  120. A distinct expression profile separates Turkish and Australian melanocytic naevi
  121. Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study
  122. Abstract B34: Global histone modifications define early stress induced drug tolerance in cancer
  123. A randomized, phase IIa exploratory trial to assess the safety and preliminary efficacy of LEO 43204 in patients with actinic keratosis
  124. The clinical relevance of dermoscopic naevus patterns
  125. Public Teledermatology Service in Queensland
  126. Mediation of improvements in sun protective and skin self-examination behaviours: results from the healthy text study
  127. Aurora A Is Critical for Survival in HPV-Transformed Cervical Cancer
  128. Teledermatologists’ management of emergency skin conditions
  129. Prior knowledge of the clinical picture does not introduce bias in the histopathologic diagnosis of melanocytic skin lesions
  130. A clinical audit of high-cost and off-label drug use in dermatology
  131. A systematic review of non-surgical treatments for lentigo maligna
  132. Grading keratinocyte atypia in actinic keratosis: a correlation of reflectance confocal microscopy and histopathology
  133. Reflectance confocal microscopy for better management of cutaneous pink lesions
  134. The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis
  135. High incidence of primary melanomas in an MC1R RHC homozygote/CDKN2A mutant genotype patient
  136. A case of gamasoidosis associated with exposure to a wild lorikeet feeding tray
  137. Smartphone diagnosis of skin cancer: there's not yet an app for that
  138. Consumer preferences for teledermoscopy screening to detect melanoma early
  139. Redefining Dermatologists’ Role in Skin Cancer Early Detection and Follow-up Care
  140. BRAF Wild-Type Melanoma in Situ Arising In a BRAF V600E Mutant Dysplastic Nevus
  141. Expression of Bcl-xL and Mcl-1 in the Nonmelanoma Skin Cancers of Renal Transplant Recipients
  142. Consumer Teledermoscopy
  143. User preferences for text message-delivered skin cancer prevention and early detection
  144. Can skin cancer prevention and early detection be improved via mobile phone text messaging? A randomised, attention control trial
  145. Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location
  146. Automated Detection of Actinic Keratoses in Clinical Photographs
  147. Sun Protection Behavior in Organ Transplant Recipients in Queensland, Australia
  148. Counting Actinic Keratosis – Is Photographic Assessment a Reliable Alternative to Physical Examination in Clinical Trials?
  149. Multiple Primary Cancers Associated with Merkel Cell Carcinoma in Queensland, Australia, 1982–2011
  150. Comparative Immune Phenotypic Analysis of Cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in Immune-Competent Individuals: Proportional Representation of CD8+ T-Cells but Not FoxP3+ Regulatory T-Cells Is Associated with Disease Stage
  151. High-contrast coherent terahertz imaging of porcine tissue via swept-frequency feedback interferometry
  152. BRAF V600E Mutation Status of Involuting and Stable Nevi in Dabrafenib Therapy With or Without Trametinib
  153. THz QCL self-mixing interferometry for biomedical applications
  154. Changeable naevi in people at high risk for melanoma
  155. Melanoma susceptibility as a complex trait: genetic variation controls all stages of tumor progression
  156. Incidence and Survival for Merkel Cell Carcinoma in Queensland, Australia, 1993-2010
  157. Lesion Selection by Melanoma High-Risk Consumers During Skin Self-examination Using Mobile Teledermoscopy
  158. Distinct melanoma types based on reflectance confocal microscopy
  159. Negative Pigment Network and Shiny White Streaks
  160. Distribution of Subsequent Primary Invasive Melanomas Following a First Primary Invasive or In Situ Melanoma in Queensland, Australia, 1982-2010
  161. Natural History of Atypical and Equivocal Melanocytic Lesions in Children: An Observational Study of 19 Cases
  162. High Aspect Ratio Elongated Microparticles for Enhanced Topical Drug Delivery in Human Volunteers
  163. Clinical Features of Actinic Keratoses and Early Squamous Cell Carcinoma
  164. Phenotypic Characterization of Nevus and Tumor Patterns in MITF E318K Mutation Carrier Melanoma Patients
  165. Mobile Medical Applications for Melanoma Risk Assessment: False Assurance or Valuable Tool?
  166. Distribution Analyses of Acquired Melanocytic Naevi on the Trunk
  167. Teledermatology for skin cancer prevention: an experience on 690 Austrian patients
  168. Defining incidental perineural invasion: the need for a national registry
  169. Skin cancer detection by one click — are we any closer?
  170. Three-dimensional modelling for estimation of nevus count and probability of nevus-melanoma progression in a murine model
  171. Zinc oxide nanoparticle removal from wounded human skin
  172. Elongate microparticles for enhanced drug delivery to ex vivo and in vivo pig skin
  173. Barriers to mobile teledermoscopy in primary care
  174. Audit of a State-wide store and forward teledermatology service in Australia
  175. A Clinico-Dermoscopic Approach for Skin Cancer Screening
  176. Unklare Hautveränderung an der Glans penis führt zu unterschiedlichen dermatoskopischen Diagnosen
  177. The opportunity for microbiopsies for skin cancer
  178. Effects of Ex Vivo Skin Microbiopsy on Histopathologic Diagnosis in Melanocytic Skin Lesions
  179. A Plea for Biobanking of All Equivocal Melanocytic Proliferations
  180. Advances in Skin Cancer Early Detection and Diagnosis
  181. Microbiopsy engineered for minimally invasive and suture-free sub-millimetre skin sampling
  182. Reflectance confocal microscopy in the diagnosis of nodular skin lesions
  183. Effects of a Chemical Sunscreen on UV-Induced Changes of Different Histological Features in Melanocytic Nevi
  184. Computational characterization of reflectance confocal microscopy features reveals potential for automated photoageing assessment
  185. Plasticity of melanoma in vivo: murine lesions resulting from Trp53, but not Cdk4 or Arf deregulation, display neural transdifferentiation
  186. Benign dermoscopic features in melanoma
  187. Dermoscopic Evaluation of Nodular Melanoma
  188. Dermoscopy use in the next generation: A survey of Australian dermatology trainees
  189. Molecular diagnosis of skin conditions via microsampling
  190. The HealthyTexts study: A randomized controlled trial to improve skin cancer prevention behaviors among young people
  191. NRAS and BRAF Mutations in Cutaneous Melanoma and the Association with MC1R Genotype: Findings from Spanish and Austrian Populations
  192. Negative pigment network: An additional dermoscopic feature for the diagnosis of melanoma
  193. The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug target
  194. Noninvasive methods for the assessment of photoageing
  195. Treatment goals for moderate to severe psoriasis: An Australian consensus
  196. Mobile Teledermatology in Sub-Saharan Africa: A Useful Tool in Supporting Health Workers in Low-resource Centres
  197. Influence of time on dermoscopic diagnosis and management
  198. Laypersons’ sensitivity for melanoma identification is higher with dermoscopy images than clinical photographs
  199. Quantifying the Orientation of Acquired Melanocytic Nevi on the Back
  200. A blueprint for staging of murine melanocytic lesions based on theCdk4R24C/R24C::Tyr-NRASQ61Kmodel
  201. Faculty Opinions recommendation of Availability of digital dermoscopy in daily practice dramatically reduces the number of excised melanocytic lesions: results from an observational study.
  202. In vivo assessment of chronological ageing and photoageing in forearm skin using reflectance confocal microscopy
  203. Correction
  204. Dermoscopy, reflectance confocal microscopy and histopathology of an amelanotic melanoma from an individual heterozygous for MC1R and tyrosinase variant alleles
  205. In Vivo Confocal Microscopic Pattern of Fibroepithelioma of Pinkus
  206. Confocal features of equivocal facial lesions on severely sun-damaged skin: Four case studies with dermatoscopic, confocal, and histopathologic correlation
  207. Personalised electronic messages to improve sun protection in young adults
  208. Dermoscopy in the Southern Hemisphere: a success story
  209. The Human Stratum Corneum Prevents Small Gold Nanoparticle Penetration and Their Potential Toxic Metabolic Consequences
  210. Introduction: The 3-point checklist
  211. The AC Rule for melanoma: A simpler tool for the wider community
  212. Modelling melanoma in mice
  213. Skin Emergency Telemedicine
  214. Teledermatology in pharmacies: a pilot study
  215. Tele-assessment of Psoriasis Area and Severity Index: A study of the accuracy of digital image capture
  216. Gold Nanoparticle Penetration and Reduced Metabolism in Human Skin by Toluene
  217. Strategies for assessing the degree of photodamage to skin: a systematic review of the literature
  218. New insights in naevogenesis: Number, distribution and dermoscopic patterns of naevi in the elderly
  219. Dermoscopic naevus patterns in people at high versus moderate/low melanoma risk in Queensland
  220. Time-Correlated Single Photon Counting For Simultaneous Monitoring Of Zinc Oxide Nanoparticles And NAD(P)H In Intact And Barrier-Disrupted Volunteer Skin
  221. Incorporating teledermatology into emergency medicine
  222. Superficial Spreading-Like Melanoma in Arf−/−::Tyr-NrasQ61K::K14-Kitl Mice: Keratinocyte Kit Ligand Expression Sufficient to “Translocate” Melanomas from Dermis to Epidermis
  223. Effectiveness and limitations of reflectance confocal microscopy in detecting persistence of basal cell carcinomas: A preliminary study
  224. Nanoparticles and microparticles for skin drug delivery
  225. First experiences using reflectance confocal microscopy on equivocal skin lesions in Queensland
  226. Dermatoscopy of genital warts
  227. Mobile teledermatology for skin tumour screening: diagnostic accuracy of clinical and dermoscopic image tele-evaluation using cellular phones
  228. Applications of multiphoton tomographs and femtosecond laser nanoprocessing microscopes in drug delivery research
  229. Pigmented spindle cell naevus of Reed: A controversial diagnostic entity in Australia
  230. Results of a nationwide dermoscopy survey investigating the prevalence, advantages and disadvantages of dermoscopy use among Australian dermatologists
  231. The User-Generated Web-Based Dermoscopy Image Archive of the International Dermoscopy Society: A Contribution to E-Learning and Exchange of Knowledge
  232. The Remote Assessment of Melanocytic Skin Lesions: A Viable Alternative to Face-to-Face Consultation
  233. Measuring performance in skin cancer practice: the SCARD initiative
  234. Key points in dermoscopy for diagnosis of melanomas, including difficult to diagnose melanomas, on the trunk and extremities
  235. Interobserver variability of teledermoscopy: an international study
  236. Shiny white streaks: An additional dermoscopic finding in melanomas viewed using contact polarised dermoscopy
  237. Differential roles of the pRb and Arf/p53 pathways in murine naevus and melanoma genesis
  238. A support vector machine for decision support in melanoma recognition
  239. LETTERS TO THE EDITOR
  240. Recent advances in diagnosing cutaneous melanomas
  241. Who benefits from prophylactic surgical removal of “dysplastic” nevi?
  242. Detection of atypical texture features in early malignant melanoma
  243. Dermoscopic presentation of a 2-mm melanoma in situ
  244. Dermoscopy and Skin Cancer
  245. Dermatoscopy of basal cell carcinoma: Morphologic variability of global and local features and accuracy of diagnosis
  246. New insights into nevogenesis: In vivo characterization and follow-up of melanocytic nevi by reflectance confocal microscopy
  247. Factors Contributing to Incomplete Excision of Nonmelanoma Skin Cancer by Australian General Practitioners
  248. Lacunarity Analysis: A Promising Method for the Automated Assessment of Melanocytic Naevi and Melanoma
  249. Mobile Teledermoscopy—Melanoma Diagnosis by One Click?
  250. Unusual clinical and dermoscopic presentation of a wart
  251. The Africa Teledermatology Project: Preliminary experience with a sub-Saharan teledermatology and e-learning program
  252. Effectiveness of 5-fluorouracil treatment for actinic keratosis - a systematic review of randomized controlled trials
  253. The Influence of Clinical Information in the Histopathologic Diagnosis of Melanocytic Skin Neoplasms
  254. Telemedicine in Skin Emergencies
  255. Fuzzy logic techniques for blotch feature evaluation in dermoscopy images
  256. Clinical and Dermoscopic Features of Porokeratosis of Mibelli
  257. Automatic detection of blue-white veil and related structures in dermoscopy images
  258. A basis function feature-based approach for skin lesion discrimination in dermatology dermoscopy images
  259. Three Roots of Melanoma
  260. State of the Art of Teledermatopathology
  261. Dermoscopic Evaluation of Amelanotic and Hypomelanotic Melanoma
  262. The Epidermal and Dermal Origin of Melanocytic Tumors: Theoretical Considerations Based on Epidemiologic, Clinical, and Histopathologic Findings
  263. Computer-Based Classification of Dermoscopy Images of Melanocytic Lesions on Acral Volar Skin
  264. A dermoscopic pitfall: Ancient melanocytic nevus
  265. Teledermatology: How to Start a New Teaching and Diagnostic Era in Medicine
  266. Teledermatology: An Update
  267. Non-melanoma skin cancers
  268. Telemedicine and teledermatology: Past, present and future
  269. Mobile teledermatology: a feasibility study of 58 subjects using mobile phones
  270. TAILPIECE
  271. Teledermatological Monitoring of Leg Ulcers in Cooperation With Home Care Nurses
  272. A dual concept of nevogenesis:Theoretical considerations based on dermoscopic features of melanocytic nevi
  273. Melanomas That Failed Dermoscopic Detection: A Combined Clinicodermoscopic Approach for Not Missing Melanoma
  274. Clinical and Dermoscopic Features of Agminated Blue Nevus
  275. Proposal of a new classification system for melanocytic naevi
  276. Dermoscopy report: Proposal for standardization
  277. Giant Pilomatricoma
  278. Feasibility of a Two-Step Teledermatologic Approach for the Management of Patients with Multiple Pigmented Skin Lesions
  279. Melanoma Screening with Cellular Phones
  280. Feasibility and diagnostic agreement in teledermatopathology using a virtual slide system
  281. Involution: The Natural Evolution of Pigmented Spitz and Reed Nevi?
  282. Dermoscopy features of melanoma incognito: Indications for biopsy
  283. Nevus Type in Dermoscopy Is Related to Skin Type in White Persons
  284. Naevus en cocarde (hoop-loop naevus)
  285. Dermoscopic Features of Difficult Melanoma
  286. The additive value of second opinion teleconsulting in the management of patients with challenging inflammatory, neoplastic skin diseases: a best practice model in dermatology?
  287. Additional dermoscopic presentation of haemosiderotic dermatofibroma
  288. Dermoscopy Key Points: Recommendations from the International Dermoscopy Society
  289. Dermoscopy Patterns of Halo Nevi
  290. Malignant Melanoma in Marathon Runners
  291. Low-resolution teledermatology: reply from authors
  292. Dermoscopy of facial nonpigmented actinic keratosis
  293. The many faces of blue nevus: A clinicopathologic study
  294. Intraepidermal Dendritic Melanocytes in Spitzoid Neoplasms
  295. Teledermatopathology: A Controlled Study About Diagnostic Validity and Technical Requirements for Digital Transmission
  296. Regression of Atypical Nevus: An Anecdotal Dermoscopic Observation
  297. Correlation with digital dermoscopic images can help dermatopathologists to diagnose equivocal skin tumours
  298. Immunotherapy of malignant melanoma – Basic principles and novel therapeutic approaches
  299. Quantitative assessment of tumour extraction from dermoscopy images and evaluation of computer-based extraction methods for an automatic melanoma diagnostic system
  300. Personal digital assistants in teledermatology
  301. Naevogenesis: new thoughts based on dermoscopy
  302. Morphologic Changes of Acquired Melanocytic Nevi With Eccentric Foci of Hyperpigmentation (“Bolognia Sign”) Assessed by Dermoscopy
  303. Mobile teledermatology coming of age
  304. Dermoscopy Improves Accuracy of Primary Care Physicians to Triage Lesions Suggestive of Skin Cancer
  305. Two years' experience with Web-based teleconsulting in dermatology
  306. Three-point checklist of dermoscopy: an open internet study
  307. Age-related prevalence of dermoscopy patterns in acquired melanocytic naevi
  308. Dermoscopy in General Dermatology
  309. The Spectrum of Spitz Nevi
  310. Prospective, Randomized, Multicenter, Double-Blind Placebo-Controlled Trial Comparing Adjuvant Interferon Alfa and Isotretinoin With Interferon Alfa Alone in Stage IIA and IIB Melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group
  311. COMMENTS AND OPINIONS
  312. Collision of basal cell carcinoma with seborrhoeic keratosis: a dermoscopic aid to histopathology?
  313. Epidermolysis bullosa naevi reveal a distinctive dermoscopic pattern
  314. Dermoscopy of an Acral Congenital Melanocytic Nevus
  315. telederm.org: Freely Available Online Consultations in Dermatology
  316. Dermoscopy for skin cancer detection
  317. Limitations of Histopathologic Analysis in the Recognition of Melanoma
  318. Dermoscopy of fibroepithelioma of pinkus
  319. Wound Teleconsultation in Patients with Chronic Leg Ulcers
  320. Teledermatology: Just Cool or a Real Tool?
  321. Do we detect a new spectrum of biologically ???benign??? melanomas in the dermoscopy era?
  322. Vascular Structures in Skin Tumors
  323. Diagnosis and categorization of acral melanocytic lesions using teledermoscopy
  324. Value of the clinical history for different users of dermoscopy compared with results of digital image analysis
  325. Dermoscopy of Subcorneal Hematoma
  326. Cutaneous inflammatory pseudotumor - a spectrum of various diseases?
  327. Which is the most reliable method for teaching dermoscopy for melanoma diagnosis to residents in dermatology?
  328. Dermoscopic features of melanoma on the scalp
  329. Dermatoscopic follow-up of a changing pigmented melanocytic skin lesion during pregnancy: from nevus to melanoma?
  330. Dermoscopy of Bowen's disease
  331. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features
  332. Internet-based program for automatic discrimination of dermoscopic images between melanomas and Clark naevi
  333. Genital lentigines and melanocytic nevi with superimposed lichen sclerosus: a diagnostic challenge
  334. CDKN2A and MC1R Mutations in Patients with Sporadic Multiple Primary Melanoma
  335. Linear discriminant analysis of dermoscopic parameters for the differentiation of early melanomas from Clark naevi
  336. Dermoscopy Features of Pigmented Squamous Cell Carcinoma: A Case Report
  337. A pilot study of a combined dermoscopic–pathological approach to the telediagnosis of melanocytic skin neoplasms
  338. UV light–induced linear IgA dermatosis
  339. Three-Point Checklist of Dermoscopy
  340. The Ultraviolet Fingerprint Dominates the Mutational Spectrum of the p53 and Ha-ras Genes in Psoralen + Ultraviolet A Keratoses from Psoriasis Patients
  341. Some Thoughts on the ‘Three-Point Checklist of Dermoscopy’ by Soyer et al.
  342. Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study
  343. The dermoscopic classification of atypical melanocytic naevi (Clark naevi) is useful to discriminate benign from malignant melanocytic lesions
  344. Dermoscopy of pigmented skin lesions: Results of a consensus meeting via the Internet
  345. Amelanotic/Hypomelanotic Melanoma - Is Dermatoscopy Useful For Diagnosis?
  346. Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts
  347. Melanocytic Nevi of Palms and Soles
  348. Melanoma Simulating Seborrheic Keratosis: A Major Dermoscopy Pitfall
  349. Unusual Herpes Simplex Virus Infection Mimicking Foreign Body Reaction After Cosmetic Lip Augmentation With Expanded Polytetrafluoroethylene Threads
  350. A Basaloid Neoplasm With Ductal Differentiation
  351. Sebaceous Carcinoma Arising from Nevus Sebaceus: A Case Report
  352. Dermoscopic and histopathologic diagnosis of equivocal melanocytic skin lesions
  353. Morphologic changes of a pigmented Spitz nevus assessed by dermoscopy
  354. Dermoscopic-pathologic correlation: an atlas of 15 cases
  355. Impact of dermoscopy on the clinical management of pigmented skin lesions
  356. Dermoscopic classification of Spitz/Reed nevi
  357. Dermoscopic classification of Clark’s nevi (atypical melanocytic nevi)
  358. Commentary: dermoscopy
  359. A novel missense mutation of NSDHL in an unusual case of CHILD syndrome showing bilateral, almost symmetric involvement
  360. “Compound blue nevus”: A reappraisal of “superficial blue nevus with prominent intraepidermal dendritic melanocytes” with emphasis on dermoscopic and histopathologic features
  361. Blueberry-Muffin-Baby
  362. Ultraviolet Exposure as the Main Initiator of p53 Mutations in Basal Cell Carcinomas from Psoralen and Ultraviolet A-Treated Patients with Psoriasis
  363. Dermoscopy of pigmented skin lesions – a valuable tool for early
  364. HISTOPATHOLOGIC CORRELATES OF DERMOSCOPIC CRITERIA
  365. Superficial Black Network: An Additional Dermoscopic Clue for the Diagnosis of Pigmented Spindle and/or Epithelioid Cell Nevus
  366. Dermoscopic criteria for melanoma in situ are similar to those for early invasive melanoma
  367. Central white scarlike patch: A dermatoscopic clue for the diagnosis of dermatofibroma
  368. Extended extracorporeal photochemotherapy with extracorporeal administration of 8-methoxypsoralen in systemic sclerosis. An Austrian single-center study
  369. Dermatoscopy in the diagnosis of pigmented skin lesions: a new semiology for the dermatologist
  370. Basaloid neoplasms in nevus sebaceus
  371. Kutane Angiosarkome
  372. Topical Treatment with Liposomes Containing T4 Endonuclease V Protects Human Skin In Vivo from Ultraviolet-Induced Upregulation of Interleukin-10 and Tumor Necrosis Factor-α
  373. Trichoblastoma and Sebaceoma in Nevus Sebaceus
  374. Solitary Skin Lesions With Histopathologic Features of Early Mycosis Fungoides
  375. Dermatoscopic pitfalls in differentiating pigmented Spitz naevi from cutaneous melanomas
  376. TME15/458: Next Generation Telemedicine Network Service for Counselling on Diagnosis of Pigmented Skin Tumours at the Point of Care
  377. Case Report. Atypical cutaneous pseudallescheriosis refractory to antifungal agents
  378. 'Tubular'structures within melanocytic proliferations: a distinctive morphologic findig not restricted to Spitz nevi
  379. Kommission Klinische Studien der ADO¶Aktuelle Stellungnahme der Arbeitsgemeinschaft Dermatologische Onkologie zur Hochdosistherapie mit Interferon α2b
  380. Oral Psoralen-UV-A for Systemic Scleroderma
  381. Reactive angioendotheliomatosis or intravascular histiocytosis? An immunohistochemical and ultrastructural study in two cases of intravascular histiocytic cell proliferation
  382. Annular elastolytic giant cell granuloma: sparing of a burn scar and successful treatment with chloroquine
  383. Giant Cell Atypical Fibroxanthoma: Does it Really Exist?
  384. Vulvar syringoma causing pruritus and carcinophobia: treatment by argon laser
  385. Hochdosistherapie mit Interferon-α2b beim malignen Melanom. Stellungnahme der Arbeitsgemeinschaft Dermatologische Onkologie der Kommission Klinische Studien der ADO
  386. Foreign Body Granulomas Due to Injectable Aesthetic Microimplants
  387. Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials
  388. CDKN2a/p16INK4a Mutations and Lack of p19ARF Involvement in Familial Melanoma Kindreds
  389. Ultraviolet Radiation of Melanocytic Nevi
  390. Long-term Follow-up and Histological Changes of Superficial Nonmelanoma Skin Cancers Treated With Topical δ-Aminolevulinic Acid Photodynamic Therapy
  391. Spiradenocylindroma-More Than a Coincidence?
  392. Großflächige kutan-subkutane Infiltrate als Nebenwirkung von Interferon-beta-Injektion
  393. CD44 and variants in melanocytic skin neoplasms
  394. Adjuvante Interferon α− Therapie beim Melanom
  395. Adjuvante Interferon-α-Therapie beim Melanom
  396. Cutaneous infiltrates of myelogenous leukemia in association with pre-existing skin diseases
  397. Standards der histo- pathologischen Diagnose maligner Melanome
  398. Ekkrine Hidradenitis
  399. Bioplastiquegranulom
  400. Influence of UVB therapy on dermoscopic features of acquired melanocytic nevi
  401. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristcs of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid?
  402. Cutaneous Leiomyosarcoma
  403. Leukemic cells within skin lesions of psoriasis in a patient with acute myelogenous leukemia
  404. Granular Cell Dermatofibroma
  405. Retikuläre Lentigo
  406. Circulating adhesion molecules as prognostic factors for cutaneous melanoma
  407. Morphological Stages of Pilomatricoma
  408. Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands
  409. Giving Credit Where It Is Due
  410. Kutanes großzelliganaplastisches Ki-1 (CD 30) positives T-Zell-Lymphom
  411. Polymerase chain reaction control of antibiotic treatment in dermatoborreliosis
  412. Influence of skin tension and formalin fixation on sonographic measurement of tumor thickness
  413. Kutane Calciphylaxie bei chronischer Niereninsuffizienz
  414. An update on pachydermodactyly and a report of three additional cases
  415. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: A multicenter case-control study of the german central malignant-melanoma registry
  416. Palmar filiform hyperkeratosis: A new paraneoplastic syndrome?
  417. Of APACHEs and PALEFACEs
  418. Sp�tmetastasierung kutaner maligner Melanome
  419. Melanotic macules following Blaschko's lines in McCune-Albright syndrome
  420. Analysis of the 14;18 translocation in cutaneous lymphomas using the polymerase chain reaction
  421. Proto-oncogene expression in dermal naevi and melanomas
  422. Widespread cutaneous necrosis in a patient with rheumatoid arthritis associated with anticardiolipin antibodies
  423. Immunohistochemical classification of cutaneous pseudolymphomas: delineation of distinct patterns
  424. EARLY DIAGNOSIS OF MALIGNANT MELANOMA BY SURFACE MICROSCOPY
  425. NK cell density in malignant skin tumours—a stereological study
  426. Faculty of 1000 evaluation for Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling.
  427. Faculty of 1000 evaluation for Ingenol mebutate gel for actinic keratosis.
  428. Faculty of 1000 evaluation for Reflectance confocal microscopy criteria for squamous cell carcinomas and actinic keratoses.
  429. Faculty of 1000 evaluation for Current issues in the management of actinic keratosis.
  430. Faculty of 1000 evaluation for Skin cancer and other cutaneous disorders in liver transplant recipients.
  431. Faculty of 1000 evaluation for Dynamic Changes in Nevi of a Patient With Melanoma Treated With Vemurafenib: Importance of Sequential Dermoscopy.
  432. Faculty of 1000 evaluation for The importance of early diagnosis and treatment of actinic keratosis.
  433. Faculty of 1000 evaluation for Spreading pigmented actinic keratosis: a review.
  434. Faculty of 1000 evaluation for Sirolimus and secondary skin-cancer prevention in kidney transplantation.
  435. Faculty of 1000 evaluation for Survival is not the only valuable end point in melanoma screening.
  436. Faculty of 1000 evaluation for Clinical and dermoscopic stability and volatility of melanocytic nevi in a population-based cohort of children in Framingham school system.
  437. Faculty of 1000 evaluation for Dermoscopy in skin self-examination: A useful tool for select patients.
  438. Faculty of 1000 evaluation for Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicine.
  439. Faculty of 1000 evaluation for Development of a two-step method for the diagnosis of melanoma by reflectance confocal microscopy.
  440. Faculty of 1000 evaluation for Dermoscopic patterns and subclinical melanocytic nests in normal-appearing skin.
  441. Faculty of 1000 evaluation for The significance of reflectance confocal microscopy in the assessment of solitary pink skin lesions.
  442. Teledermatopathology: Current Status and Perspectives
  443. The Morphologic Dimension in the Diagnosis of Melanocytic Skin Lesions
  444. Teledermatology
  445. Common Nevus
  446. Atypical (Dysplastic) Nevus